Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM.NS

404.65 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q2
Revenue 614.39434.86472.34578.29601.53554.541601.398605.262605.969521.355544.739594.887599.986427.665571.043563.527316.521295.175420.104418.059452.34384.022418.945441.249424.04326.731380.565289.068268.965293.589343.824400.19402.417392.033346.107332.78369.885388.486324.286329.606339.131312.808377.016367.897380.788381.331493.212417.833372.269414.619465.967476.549
Cost of Revenue 405.4317.87197.41209.09222.89234.033228.4209.376255.259242.937217.337235.082265.701152.055252.878278.944125.46378.68139.854158.87184.907139.557179.664196.571213.529112.691203.08155.124140.20686.893171.186168.772162.646142.861126.424128.497193.451228.171156.942148.112153.60967.344189.614178.484211.618214.702264.682207.829174.409191.384220.679228.948
Gross Profit 208.99116.99274.93369.2378.64320.508372.998395.886350.71278.418327.402359.805334.285275.61318.165284.583191.058216.495280.25259.189267.433244.465239.281244.678210.511214.04177.485133.944128.759206.696172.638231.418239.771249.172219.683204.283176.434160.315167.344181.494185.522245.464187.402189.413169.17166.629228.53210.004197.86223.235245.288247.601
Gross Profit Ratio 0.340.2690.5820.6380.6290.5780.620.6540.5790.5340.6010.6050.5570.6440.5570.5050.6040.7330.6670.620.5910.6370.5710.5550.4960.6550.4660.4630.4790.7040.5020.5780.5960.6360.6350.6140.4770.4130.5160.5510.5470.7850.4970.5150.4440.4370.4630.5030.5310.5380.5260.52
Reseach & Development Expenses 00000000000003.4580001.5410001.2090003.7430005.6440004.6880003.2850005.5480006.933000000
General & Administrative Expenses 00000-50.923000165.93500018.8000122.09000000000000000000000000.4520000.4000000
Selling & Marketing Expenses 00000154.65000102.1900096.222000162.940000000000000000000000038.54700038.262000000
SG&A 117.3394.3398.03126.7179.04103.727104.868117.015148.815268.125151.319140.8297.674115.022153.32156.58118.198285.03146.164124.69131.451122.424127.404126.476106.242123.473104.214110.49795.866114.81196.787101.144111.611125.86992.17496.74682.3694.79574.4875.4689.5328.81891.35497.29887.489333.71398.2296.3730000
Other Expenses 14.4424.8725.2122.7419.9728.1517.40911.2073.135-28.82619.5362.8498.218-13.7385.3484.1357.845203.6926.5084.4386.712-4.1742.786220.580.879225.199198.1450.001169.1031.187166.024216.418222.267209.136202.697186.24157.776150.427155.8150.001163.363214.62164.84177.271155.5862.912199.817189.968184.7763.214203.233204.538
Operating Expenses 117.3394.33245.09290.1296.2270.995289.96268.899288.461273.723274.99259.273244.374219.144256.081238.987167.341203.692257.205236.783247.922211.838219.582220.58200.591225.199198.145171.477169.103204.567166.024216.418222.267209.136202.697186.24157.776150.427155.815163.769163.363214.62164.84177.271155.586154.995199.817189.968184.776195.708203.233204.538
Operating Income 91.6622.6655.05101.8482.4477.634100.447138.19462.249-2.98552.412100.53289.91156.46662.08445.59623.71712.80323.04522.40619.51132.62719.69924.0989.92-11.159-22.926-39.44842.2070.974128.6836.2938.01723.5884.8645.9756.325-0.6810.3286.97110.09812.52811.740.9590.086-2.08915.547.4941.50612.69731.74632.701
Operating Income Ratio 0.1490.0520.1170.1760.1370.140.1670.2280.103-0.0060.0960.1690.150.1320.1090.0810.0750.0430.0550.0540.0430.0850.0470.0550.023-0.034-0.06-0.1360.1570.0030.3740.0160.020.060.0140.0180.017-0.0020.0010.0210.030.040.0310.0030-0.0050.0320.0180.0040.0310.0680.069
Total Other Income Expenses Net -20.5622.7-2.26-2.2118.47-4.422-1.771-0.259-55.046-1.78418.9552.2157.16417.3653.9922.9676.5362.3955.4962.9575.5354.7431.744-1.974-0.829-0.528-2.266-1.914-1.863-1.155122.069-8.707-9.487-16.448-12.122-12.068-12.333-10.569-11.201-10.753-12.061-18.316-10.822-11.183-13.498-10.811-13.173-12.542-11.578-11.616-10.309-10.362
Income Before Tax 71.145.3652.7999.63100.9173.21298.676137.9357.2032.00271.367102.74797.07573.83166.07648.56330.25315.19828.54125.36325.04637.3721.44322.1249.091-11.687-22.926-39.447-42.2070.974128.6836.2938.01723.5884.8645.9756.325-0.6810.3286.97210.09812.52811.740.9590.0860.82315.547.4941.50615.91131.74632.701
Income Before Tax Ratio 0.1160.1040.1120.1720.1680.1320.1640.2280.0120.0040.1310.1730.1620.1730.1160.0860.0960.0510.0680.0610.0550.0970.0510.050.021-0.036-0.06-0.136-0.1570.0030.3740.0160.020.060.0140.0180.017-0.0020.0010.0210.030.040.0310.00300.0020.0320.0180.0040.0380.0680.069
Income Tax Expense 17.819.8713.1624.9125.917.18720.82733.8123.511.75217.30229.67328.59422.84211.7738.4755.05-0.355.7095.0725.0097.62444.4251.8180.608-0.456-0.9130-7.18429.6411.261.6033.5771.3731.591.67-1.360.0663.330.3082.8480.90.05-2.4644.73.31.56.5078.5237.3
Net Income 53.2935.4939.6374.7274.7956.02277.85104.1233.6930.2554.06573.07468.48150.98954.30340.08825.20315.54822.83220.29120.03729.74617.44317.6997.273-12.295-22.47-38.534-42.2078.15899.0425.0336.41420.0113.4914.3854.6550.6790.2623.6727.09812.228.8920.0590.0363.28710.844.1940.0069.40323.22325.401
Net Income Ratio 0.0870.0820.0840.1290.1240.1010.1290.1720.00600.0990.1230.1140.1190.0950.0710.080.0530.0540.0490.0440.0770.0420.040.017-0.038-0.059-0.133-0.1570.0280.2880.0130.0160.0510.010.0130.0130.0020.0010.0110.0210.0390.024000.0090.0220.0100.0230.050.053
EPS 2.011.311.512.852.852.142.973.970.140.012.022.512.611.942.071.530.960.590.870.770.761.140.670.680.28-0.47-0.86-1.47-1.610.313.780.190.240.760.130.170.180.0250.010.140.270.470.340.0020.0010.130.410.1600.360.890.97
EPS Diluted 1.931.311.472.852.852.142.973.970.140.012.022.512.611.942.071.530.960.590.870.770.761.140.670.680.28-0.47-0.86-1.47-1.610.313.780.190.240.760.130.170.180.0250.010.140.270.470.340.0020.0010.130.410.1600.360.890.97
EBITDA 102.3826.6959.17106.39106.3482.422103.746140.22967.316-2.46875.649105.658100.96374.39370.17552.47834.30718.68932.14829.51629.08439.90224.79126.59713.339-11.008-20.449-37.343-37.6975.6049.94322.2824.54749.32824.40825.35125.57215.49118.70524.90629.26837.69529.95219.24420.49518.09735.81627.02819.60233.32749.60549.278
EBITDA Ratio 0.1670.0610.1250.1840.1770.1490.1730.2320.111-0.0050.1390.1780.1680.1740.1230.0930.1080.0630.0770.0710.0640.1040.0590.060.031-0.034-0.054-0.129-0.140.0190.0290.0560.0610.1260.0710.0760.0690.040.0580.0760.0860.1210.0790.0520.0540.0470.0730.0650.0530.080.1060.103